未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Changes in key volatile components associated with leaf quality of Pandanus amaryllifolius Roxb. alongside growth duration
Yan, Lu; Zhang, Ang; Qin, Xiaowei; Yu, Huan; Ji, Xunzhi; He, Shuzhen; Zong, Ying; Gu, Chunhe; Feng, Zhen; Hu, Lisong; Lu, Zhiqing
分享
收藏Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialvunakizumab治疗中至重度慢性斑块状银屑病的疗效和安全性: 一项随机,双盲,安慰剂对照的3期试验
Yan, Kexiang; Li, Fuqiu; Bi, Xiaodong; Han, Ling; Zhang, Zhenghua; Chen, Rixin; Li, Yuye; Zhang, Litao; Wang, Xiaohua; Li, Linfeng; Lu, Jianyun; Xu, Ai'e; Yang, Sen; Lu, Yan; Sun, Jianfang; Li, Zhiming; Zhu, Xiaohong; Jiang, Meiying; Zhang, Siping; Wang, Wenqing; Li, Yanling; Meng, Zudong; Li, Hongyi; Mou, Kuanhou; Han, Xiuping; Li, Shanshan; Chen, Aijun; Li, Xin; Liu, Donghua; Zhang, Chunlei; Ji, Chao; Wang, Yu; Cheng, Hao; Cui, Xiaojing; Yao, Xiaoyan; Bai, Xiaoyan; Dong, Guangchao; Xu, Jinhua
分享
收藏Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial德库拉瓦西替尼(Deucravacitinib),一种口服的选择性别构酪氨酸激酶2(tyrosine kinase 2)抑制剂,在中国大陆、台湾和韩国的中重度斑块状银屑病患者中的研究:一项III期随机临床试验
Zhang, Jianzhong; Ding, Yangfeng; Wang, Ping; Li, Linfeng; Pan, Weili; Lu, Yan; Cheng, Hao; Jiang, Xian; Ho, Ji-Chen; Guo, Shuping; Liu, Leona; Chatterjee, Arkendu; Kisa, Renata M.; Banerjee, Subhashis
分享
收藏
分享
收藏
分享
收藏